Nearly monodispersed CuIn 0.7 Ga 0.3 Se 2 (CIGS) nanocrystals were successfully prepared using the thermal decomposition of copper, indium (In), gallium (Ga), and selenium-oleylamine (OLA) complexes via the heating-up process. The phase formation sequence was CuSe-CuInSe 2 -CIGS. The CIGS nanocrystals synthesized using the heating-up process exhibited a single chalcopyrite phase and its chemical composition was close to stoichiometric. However, phase separation of the In-rich and Ga-rich phases was found using the hot-injection method due to the difference in reactivity between In-OLA and Ga-OLA complexes.
CuInSe2 (CIS) powders were synthesized using CuSe, Cu2Se, and In2Se3 as the raw materials. The formation mechanisms and reaction kinetics from CuSe/In2Se3 and Cu2Se/In2Se3 powders in a selenium atmosphere were investigated. It was observed that the formation temperature of α‐CIS powders synthesized using Cu2Se/In2Se3 as the raw materials was higher than that using CuSe/In2Se3. Both reactions for Cu2Se/In2Se3 and CuSe/In2Se3 mixtures follow one‐dimensional diffusion‐controlled reactions with apparent activation energies of 124.3 and 73.2 kJ/mol, respectively. For both mixtures the indium‐rich β‐CIS phase resulting from Cu+ ion diffusion toward the In2Se3 phase was observed. The particle size and morphology of the newly formed CIS was similar to In2Se3, which indicated that the CIS formation kinetics may be dominated by the diffusion of Cu+ ions. The Cu–Se liquid phase resulting from the peritectic decomposition of CuSe2 and CuSe at a relatively low temperature may promote Cu+ diffusion into the In2Se3 surface, assisting CIS formation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.